Please login to the form below

Not currently logged in
Email:
Password:

National Cancer Institute

This page shows the latest National Cancer Institute news and features for those working in and with pharma, biotech and healthcare.

FDA will maintain the pace, vows Woodcock, but warns of skills gap

FDA will maintain the pace, vows Woodcock, but warns of skills gap

His successor, Ned Sharpless has been drafted in from his former role as head of the National Cancer Institute (NCI), but remains for now an interim Commissioner, and one certainly less

Latest news

More from news
Approximately 1 fully matching, plus 84 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    As Director of the MRC Clinical Trials Unit she has led the National Cancer Research Network in applying clinical trials for the improvement of cancer management in the UK. ... She now sits in the House of Lords as an independent peer, and is chair of

  • An effective commercial model for cancer care An effective commercial model for cancer care

    Treatments for cancer are among the most expensive of all, regardless of disease. ... In an online survey of 8, 411 cancer patients administered by LIVESTRONG (the Lance Armstrong Foundation) and the National Cancer Institute's Health Information

  • EATRIS and the new age of partnering EATRIS and the new age of partnering

    In a display of its global ambition, EATRIS is joining with Cancer Research UK to bring representatives of the US's National Cancer Institute to a workshop in Brussels in October ... In October the National Cancer Institute will meet with specialists -

  • Diagnostics are rising up the pharma value chain Diagnostics are rising up the pharma value chain

    According to the US National Cancer Institute, about 12 per cent of women in the general population will develop breast cancer sometime during their lives. ... lung cancer, which was backed together with Roche Diagnostics' cobas EGFR Mutation Test.

  • Country report: The healthcare market in France Country report: The healthcare market in France

    National Cancer Institute (NCI) or the National Institute for Prevention and Education for Health (NIPEH). ... This applies to oncology drugs under France's national cancer care plan that includes fast access to new therapies.

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Publicis Resolute

Publicis Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team with a...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics